167 related articles for article (PubMed ID: 29108315)
1. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy.
Shi S; Chen Q; Ye L; Yin D; Li X; Dai Z; He J
Oncotarget; 2017 Oct; 8(45):79366-79375. PubMed ID: 29108315
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.
Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q
J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.
Fu S; Guo Z; Li S; Kuang M; Hu W; Hua Y; He X; Peng B
Tumour Biol; 2016 Mar; 37(3):3433-40. PubMed ID: 26449826
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomograms.
Liao C; Li G; Bai Y; Zhou S; Huang L; Yan M; Qiu F; Chen J; Wang Y; Tian Y; Chen S
J Gastrointest Oncol; 2021 Apr; 12(2):669-693. PubMed ID: 34012658
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy.
Feng H; Xu F; Zhao Y; Jin T; Liu J; Li R; Zhou T; Dai C
Front Oncol; 2022; 12():947302. PubMed ID: 36132141
[TBL] [Abstract][Full Text] [Related]
9. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y
BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection.
Itoh S; Yugawa K; Shimokawa M; Yoshiya S; Mano Y; Takeishi K; Toshima T; Maehara Y; Mori M; Yoshizumi T
BJS Open; 2019 Aug; 3(4):500-508. PubMed ID: 31388642
[TBL] [Abstract][Full Text] [Related]
11. A Novel Prognostic Scoring Model Based on Albumin and γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis.
Wang L; Li Q; Zhang J; Lu J
Cancer Manag Res; 2019; 11():10685-10694. PubMed ID: 31920379
[TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection.
Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y
J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
16. Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma.
Hong YF; Chen ZH; Wei L; Ma XK; Li X; Wen JY; Wang TT; Cai XR; Wu DH; Chen J; Ruan DY; Lin ZX; Lin Q; Dong M; Wu XY
Oncol Lett; 2017 Aug; 14(2):2089-2096. PubMed ID: 28789436
[TBL] [Abstract][Full Text] [Related]
17. Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection.
Li GJ; Ji JJ; Yang F; Xu HW; Bai Y
Onco Targets Ther; 2017; 10():1181-1189. PubMed ID: 28260933
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
19. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]